All entries for: Axsome Therapeutics, Inc.

May 4, 2026

Axsome Therapeutics, Inc.

Negative Outlook

New York, NY
201-500 employees

We are evaluating what effect, if any, the IRA may have on our business. Any reduction in reimbursement from Medicare or other government healthcare programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drugs.

Disease Area: Chronic Disease, Neurological Diseases
Drug Type: Small Molecule
February 23, 2026

Axsome Therapeutics, Inc.

Neutral Outlook

New York, NY
201-500 employees

The impact of the IRA on the broader pharmaceutical industry remains to be seen.

Disease Area: Chronic Disease, Neurological Diseases
Drug Type: Small Molecule
Scroll to Top